Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1

Status

Completed 133Terminated 28Active not recruiting 10Withdrawn 8Unknown 4Recruiting 4

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2Lymphoid 1Gastrointestinal 1

Conditions

Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Kidney Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Interventional × temsirolimus × Clear all
NCT03571438 2020-01-18

COMBOREIN

University Hospital, Grenoble

Phase NA Unknown
100 enrolled
Genitourinary

Kidney Neoplasms

NCT01653067 2016-10-27

STORM

University Hospital Heidelberg

Phase 2 Unknown
88 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT01567930 2012-12-17

Temsirolimus as Second-line Therapy in HCC

University of Tennessee Cancer Institute

Phase 2 Unknown
25 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01246817 2012-04-11

Temsirolimus-RCC-imaging

Radboud University Medical Center

Phase 2 Unknown
51 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡